Recognize When to Recommend Qulipta for Migraine Prevention
March 2023
Qulipta (atogepant) will be the first oral “gepant” to PREVENT migraine in adults.
It blocks calcitonin gene-related peptide (CGRP)...similar to injectable CGRP antagonists (Aimovig, etc) used for migraine prevention.
Evidence suggests Qulipta prevents about 1 migraine day/month more than placebo in patients with an average of 8 migraine days/month...after 3 months of use.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive